X @Bloomberg
Bloomberg·2026-02-03 19:17
OpenAI Chief Executive Officer Sam Altman said his company may consider investing in or subsidizing firms that make significant use of its AI technologies to discover new drugs or therapies, and possibly take a royalty in exchange https://t.co/cAzixe8zuc ...